SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.45-0.4%Dec 23 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: opalapril who wrote (8270)1/13/1999 3:47:00 AM
From: Tharos  Read Replies (1) of 17367
 
Yes, I hope we hear something soon. I figured they may be delaying info because of the move and the desire to make the tax burden as small as possible. But now the move is over. I lean towards DSMB recommendation for approval, but with just barely enough statistical significance to pass. Reason being other improved treatments. Yet I feel the quality of treatment in regards to amputations and deformations will give Neuprex the edge it needs to get the go-ahead.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News